This study seeks to evaluate the use of intermittent dosing as an alternative paradigm for patients with DRG stimulation in place for at least 1 year and minim…

CRPS (Complex Regional Pain Syndromes)RadiculopathyPeripheral Neuropathy

~Estimated

~$10 – $6,250

Rush University Medical CenterNCT04909138

Phase 4

Postpartum Activity and Expression of BCRP and OCT1 Drug Transporters in the Mammary Gland

This is a prospective, non-randomized, phase I study design evaluating the in vivo activities and expression of OCT1 and BCRP in mammary gland of lactating wom…

PostpartumLactationDrugs in Breast Milk+3 more

~Estimated

~$10 – $6,250

University of WashingtonNCT06056583

Phase 1

A Phase 1/2, Open-Label, Randomized, Dose Finding and Dose Expansion Study of Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisib in combi…

mCRPC (Metastatic Castration-resistant Prostate Cancer)Genital Diseases, MaleUrogenital Diseases, Male+3 more

~Estimated

~$10 – $8,750

Celcuity IncNCT06190899

← PreviousPage 4 of 4Next →